Viatris (VTRS) Receivables - Net (2019 - 2026)
Viatris (VTRS) recorded quarterly Receivables - Net of $3.1 billion in Q1 2026, up 1.48% quarter-over-quarter from $3.0 billion in Q4 2025, and up 19.01% on a YoY basis from $2.6 billion in Q1 2025.
Viatris (VTRS) Receivables - Net (2019 - 2026) Analysis & Trends
Viatris' Receivables - Net history runs 8 years deep, the most recent figure standing at $3.1 billion for Q1 2026.
- In Q1 2026, Receivables - Net rose 19.01% year-over-year to $3.1 billion; the TTM figure through Mar 2026 stood at $3.1 billion (up 19.01% YoY), while the FY2025 annual figure was $3.0 billion, down 5.9% from the prior year.
- Receivables - Net was $3.1 billion for Q1 2026 at Viatris, up from $3.0 billion in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $4.1 billion in Q1 2022 to a low of $2.6 billion in Q1 2025.
- Historically, Receivables - Net has averaged $3.4 billion across 5 years, with a median of $3.5 billion in 2023.
- The sharpest annual moves came in 2022 and 2023: Receivables - Net slumped 34.88% in 2022, then surged 32.11% in 2023.
- A 5-year view of Receivables - Net shows it stood at $3.8 billion in 2022, then declined by 2.99% to $3.7 billion in 2023, then decreased by 12.95% to $3.2 billion in 2024, then declined by 5.9% to $3.0 billion in 2025, then grew by 1.48% to $3.1 billion in 2026.
- The last three Receivables - Net figures came in at $3.1 billion (Q1 2026), $3.0 billion (Q4 2025), and $3.4 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Viatris | - | - | 1.16 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.08 Bn |
| Mar 31, 2026 | 3.08 Bn |
| Dec 31, 2025 | 3.03 Bn |
| Dec 31, 2025 | 3.03 Bn |
| Sep 30, 2025 | 3.37 Bn |
| Sep 30, 2025 | 3.37 Bn |
| Jun 30, 2025 | 3.26 Bn |
| Jun 30, 2025 | 3.26 Bn |
| Mar 31, 2025 | 2.58 Bn |
| Mar 31, 2025 | 2.58 Bn |
| Dec 31, 2024 | 3.22 Bn |
| Dec 31, 2024 | 3.22 Bn |
| Sep 30, 2024 | 2.86 Bn |
| Sep 30, 2024 | 2.86 Bn |
| Jun 30, 2024 | 3.57 Bn |
| Jun 30, 2024 | 3.57 Bn |
| Mar 31, 2024 | 3.63 Bn |
| Mar 31, 2024 | 3.63 Bn |
| Dec 31, 2023 | 3.70 Bn |
| Dec 31, 2023 | 3.70 Bn |